While it is well-known that weight loss from lifestyle changes or bariatric surgery increases testosterone levels, the impact that anti-obesity medications may also have on these levels has not been widely studied, said Dr
A clinical trial investigated the effect of 8-week metformin treatment on aging individuals with mild cognitive impairment (MCI) or early AD, and the results revealed that metformin is associated with improved executive function, companied by improvement in learning/memory and attention [27]
Semaglutide gained FDA approval for MASH, as well as FDA and EMA approval in chronic kidney disease
He predicts that dedicated rheumatology use of GLP-1 drugs is likely to arrive in the near future as evidence grows.
Who Should NOT Use Them (Contraindications): GLP-1 medications are not suitable for everyone
Back Couzin-Frankel, J (6 Sept 2023) 'Her work paved the way for blockbuster obesity drugs